Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
life sciences
national blog main
clinical trials
san francisco blog main
san francisco top stories
biotech
cancer
national top stories
new york blog main
new york top stories
sanofi
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
andrew berens
anirvan ghosh
astrazeneca
avapritinib
biogen
blueprint medicines
bluerock therapeutics
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer diagnostics
cancer immunotherapy
cerovene
cholesterol
covid-19
crispr
data
deals
deciphera pharmaceuticals
deerfield management
What
announced
4
×
medicine
plans
cancer
ceo
drug
medicines
week
aces
acquisitions
approval
area
based
bay
big
bio
biopsy
blood
blueprint
buildout
chasing
cholesterol
close
collabs
company
covid
daniel
deadly
deal
deciphera
developing
fda
filing
firm
flexible
forms
genomic
gi
gilead
gilead’s
Language
unset
4
×
Current search:
unset
×
announced
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug